Literature DB >> 25784390

Biomarkers of acromegaly.

Luis V Syro1, Fabio Rotondo, Kalman Kovacs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25784390     DOI： 10.1007/s12020-015-0579-9

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  6 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Growth hormone tumor histological subtypes predict response to surgical and medical therapy.

Authors:  Katja Kiseljak-Vassiliades; Nichole E Carlson; Manuel T Borges; B K Kleinschmidt-DeMasters; Kevin O Lillehei; Janice M Kerr; Margaret E Wierman
Journal:  Endocrine       Date:  2014-08-17       Impact factor: 3.633

Review 3.  Biomarkers of aggressive pituitary adenomas.

Authors:  Ozgur Mete; Shereen Ezzat; Sylvia L Asa
Journal:  J Mol Endocrinol       Date:  2012-08-30       Impact factor: 5.098

Review 4.  Biomarkers of pituitary neoplasms.

Authors:  Aydin Sav; Fabio Rotondo; Luis V Syro; Bernd W Scheithauer; Kalman Kovacs
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

5.  Therapeutic implications of accurate classification of pituitary adenomas.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Semin Diagn Pathol       Date:  2013-08       Impact factor: 3.464

6.  Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis.

Authors:  Alev Selek; Berrin Cetinarslan; Yesim Gurbuz; Ilhan Tarkun; Zeynep Canturk; Burak Cabuk
Journal:  Endocrine       Date:  2014-10-10       Impact factor: 3.633
  6 in total
  1 in total

Review 1.  Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.

Authors:  Luis V Syro; Fabio Rotondo; Carlos A Serna; Leon D Ortiz; Kalman Kovacs
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.